Methotrexate

JUL 31, 2026 · PHASE 2 TRIAL

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

ClinicalTrials.gov

This is an active interventional Phase 2 trial registry record with no results reported; it describes a planned study of premedication strategies to reduce amivantamab infusion reactions in non-small-cell lung cancer.

MAY 27, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Methotrexate (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for methotrexate labeling update; regulatory action does not report clinical trial outcomes or efficacy data.

MAY 27, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Jylamvo (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for methotrexate oral solution labeling change; regulatory action only, no clinical trial data presented.

MAY 27, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Trexall (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling change to methotrexate tablet formulations; documents regulatory action only, not clinical trial data.

MAY 27, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Methotrexate (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval for labeling changes to methotrexate; it documents a regulatory action, not clinical evidence of efficacy or safety.